scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1016/J.ANNEPIDEM.2007.11.011 |
P698 | PubMed publication ID | 18261926 |
P2093 | author name string | Elaine M Smith | |
Leslie K Dennis | |||
Anuja Dokras | |||
Robin M Beining | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
P304 | page(s) | 492-499 | |
P577 | publication date | 2008-02-08 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Annals of Epidemiology | Q4767848 |
P1476 | title | Meta-analysis of intrauterine device use and risk of endometrial cancer | |
P478 | volume | 18 |
Q47612930 | Assessing the Role of Reversible Contraceptives in the Health Care of Women as it Pertains to Cancer Prevention |
Q55713330 | Benefits of reversible contraception. |
Q64891209 | Cancer Progress and Priorities: Uterine Cancer. |
Q37661580 | Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer |
Q36999466 | Contemporary Clinical Management of Endometrial Cancer |
Q34287368 | Contraception and health |
Q39041540 | Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia |
Q38810122 | Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040. |
Q38788210 | Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences |
Q38018780 | Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception |
Q64108528 | Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors |
Q53145962 | Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies |
Q34713871 | Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium |
Q64916377 | Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. |
Q37293672 | Molecular pathogenesis of endometrial and ovarian cancer |
Q38513642 | Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods |
Q36948873 | Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin |
Q34272031 | Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS |
Q33540807 | State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices |
Q35676052 | The Epidemiology of Endometrial and Ovarian Cancer |
Q33875057 | Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States |
Q34690392 | Understanding obesity and endometrial cancer risk: opportunities for prevention |
Q34930051 | Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. |
Search more.